Mavacamten is approved to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). However, its effects ...

Patients benefit from antiplatelet therapy after coronary-artery bypass grafting (CABG) for an acute coronary syndrome.

An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction ...

Beta-blockers have been the initial treatment for symptomatic obstructive hypertrophic cardiomyopathy (HCM) despite limited ...

Poorly controlled hypertension is a common problem worldwide, particularly in low-resource settings. We conducted an ...

A 37-year-old woman presented to the emergency department with a 4-day history of acute pain, swelling, and bruising on the upper portion of the left knee after using an electronic massage gun. Her ...

A 61-year-old woman presented to the emergency department with chest pain. ST-segment elevations were revealed on ECG. A coronary angiogram showed normal coronary arteries, but left ventriculography ...

China has recently emerged as an important player in new drug development — a field traditionally dominated by the United States and Europe. This shift has implications for global access to new ...

Venous thromboembolism is a common complication of cancer and its treatments, and the incidence of recurrent thrombosis, serious bleeding, and death is higher among patients with this condition than ...

The story of the patient-safety movement is one of slow progress punctuated by episodes of inspiring successes that are slow to be replicated. So it is not surprising that when promising innovations ...

To the Editor: In the SELECT trial, Lincoff and colleagues (Dec. 14 issue) 1 found that weekly subcutaneous semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, was superior to placebo in ...

The medical school application process has spiraled out of control, placing a huge and counterproductive burden on young aspiring physicians. What can be done to scale things down while improving t ...